Obesity and hypertension: two epidemics or one? (Q34311562)

1 August 2017

1 reference

title

Obesity and hypertension: two epidemics or one? (English)

1 reference

1 August 2017

0 references

1 reference

Kevin P Davy

1

1 reference

PubMed ID

15068965

1 August 2017

John E Hall

series ordinal

2

1 reference

1 August 2017

1 May 2004

1 reference

American Journal of Physiology - Regulatory, Integrative and Comparative Physiology

1 August 2017

1 reference

1 August 2017

286

1 reference

1 August 2017

R803-13

1 reference

1 August 2017

5

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

1 August 2017

1 reference

Management of obesity cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Obesity is independently associated with coronary endothelial dysfunction in patients with normal or mildly diseased coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Subcutaneous obesity is not associated with sympathetic neural activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Autonomic nervous system activity in weight gain and weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

The effect of weight loss with or without exercise training on large artery compliance in healthy obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Plasma leptin and blood pressure in men: graded association independent of body mass and fat pattern

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Hypertension and the metabolic syndrome: closely related central origin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Elevated intra-abdominal pressure increases plasma renin activity and aldosterone levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

The effects of weight loss on renal function in patients with severe obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Cardiac lipid accumulation associated with diastolic dysfunction in obese mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Comparison of aortic elasticity determined by cardiovascular magnetic resonance imaging in obese versus lean adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

The independent and combined effects of weight loss and aerobic exercise on blood pressure and oral glucose tolerance in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Treatment of obesity: need to focus on high risk abdominally obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Body mass index, abdominal adiposity and blood pressure: consistency of their association across developing and developed countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Ten-year incidence of elevated blood pressure and its predictors: the CARDIA study. Coronary Artery Risk Development in (Young) Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Physiology and pathophysiology of the adipose tissue renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

On a low calorie diet, are there separate and discrete effects of negative energy balance and weight loss on blood pressure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

The sympathetic neurobiology of essential hypertension: disparate influences of obesity, stress, and noradrenaline transporter dysfunction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Sympathetic nervous system and insulin resistance: from obesity to diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Impact of visceral fat on blood pressure and insulin sensitivity in hypertensive obese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Prevalence and Trends in Obesity Among US Adults, 1999-2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Effects of weight loss on clinic and ambulatory blood pressure in normotensive men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: results of the CROSS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Participation of the hypothalamus-hypophysis axis in the sympathetic activation of human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

The role of exercise training in the treatment of hypertension: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Pathophysiology of obesity hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

The kidney, hypertension, and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Role of sympathetic nervous system and neuropeptides in obesity hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Obesity hypertension: role of leptin and sympathetic nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Impact of the obesity epidemic on hypertension and renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Obesity-associated hypertension and kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Cardiovascular consequences of obesity: role of leptin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Relationship of co-morbidities of obesity to weight loss and four-year weight maintenance/rebound.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Reduction of left ventricular hypertrophy after exercise and weight loss in overweight patients with mild hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Body weight, weight change, and risk for hypertension in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Relationship between changes in serum leptin levels and blood pressure after weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Obesity and the risk of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Effect of sibutramine on weight loss and blood pressure: a meta-analysis of controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Changes in risk factors for cardiovascular disease with body fat loss in obese women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Weight loss and weight maintenance, ambulatory blood pressure and cardiac autonomic tone in obese persons with the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Insulin sensitivity in the pathogenesis of hypertension and hypertensive complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Aortic stiffness is an independent predictor of fatal stroke in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Palmitate-induced apoptosis can occur through a ceramide-independent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

High prevalence of unrecognized sleep apnoea in drug-resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Sustained activation of the central baroreceptor pathway in obesity hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Correlates of aortic stiffness in elderly individuals: a subgroup of the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Weight gain-induced blood pressure elevation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Differences in mechanisms between weight loss-sensitive and -resistant blood pressure reduction in obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Endothelin contributes to basal vascular tone and endothelial dysfunction in human obesity and type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Effects of intravenous infusions of angiotensin II on muscle sympathetic nerve activity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Visceral fat accumulation and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

A randomized trial of improved weight loss with a prepared meal plan in overweight and obese patients: impact on cardiovascular risk reduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Results of the Diet, Exercise, and Weight Loss Intervention Trial (DEW-IT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Echocardiographic abnormalities in normotensive obese patients: relationship with visceral fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Overexpression of apolipoprotein B in the heart impedes cardiac triglyceride accumulation and development of cardiac dysfunction in diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Popular diets: a scientific review

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Arterial stiffness, systolic blood pressure, and logical treatment of arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Obesity and body fat distribution induce endothelial dysfunction by oxidative stress: protective effect of vitamin C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Sleep apnea and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Recent developments in the treatment of obesity-related hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Obesity, salt intake, and renal perfusion in healthy humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Banting lecture 1988. Role of insulin resistance in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Effects of weight reduction on arterial pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Lisinopril versus hydrochlorothiazide in obese hypertensive patients: a multicenter placebo-controlled trial. Treatment in Obese Patients With Hypertension (TROPHY) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Direct magnetic resonance determination of aortic distensibility in essential hypertension: relation to age, abdominal visceral fat, and in situ intracellular free magnesium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Hypertension in Obesity and the Leptin Receptor Gene Locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Body fat and sympathetic nerve activity in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Blood pressure reductions with exercise and sodium restriction in postmenopausal women with elevated systolic pressure: role of arterial stiffness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Effect of orlistat-induced weight loss on blood pressure and heart rate in obese patients with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

The relationship of waist circumference to blood pressure: the Olivetti Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Differentiated long-term effects of intentional weight loss on diabetes and hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Relationship between muscle sympathetic nerve activity and plasma leptin concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Obesity Hypertension in Children: A Problem of Epidemic Proportions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Blood pressure and hormone changes associated with weight reduction in the obese.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Reduced sympathetic nervous activity. A potential mechanism predisposing to body weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Effects of exercise and weight loss on blood pressure during daily life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Intra-abdominal pressure, sagittal abdominal diameter and obesity comorbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Relationship of fat mass and fat distribution to blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Plasma angiotensinogen concentrations in obese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

The physiology of cellular liporegulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Leptin secretion from subcutaneous and visceral adipose tissue in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Pharmacological therapy of obesity: past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Measures of obesity are associated with vascular stiffness in young and older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Antihypertensive effect of alpha- and beta-adrenergic blockade in obese and lean hypertensive subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Obesity, Sleep Apnea, and Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Role of endothelium in thrombosis and hemostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

Epidemiology of obstructive sleep apnea: a population health perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00707.2003

10.1152/AJPREGU.00707.2003

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

15068965